Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues

Published:2018-11-14 Issue:2 Volume:26 Page:278-286
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Chevaliez Stéphane¹²^ORCID,Rodriguez Christophe¹²,Poiteau Lila¹²,Soulier Alexandre¹²,Donati Flora¹²,Darty-Mercier Mélanie¹²,Pioche Corinne³,Leroy Vincent⁴⁵,Brodard Véronique⁶,Zoulim Fabien⁷⁸^ORCID,Brouard Cécile³,Larsen Christine³,Semaille Caroline³,Roudot-Thoraval Françoise⁹,Pawlotsky Jean-Michel¹²,

Affiliation:

1. Department of Virology; Hôpital Henri Mondor; National Reference Center for Viral Hepatitis B, C and D; Université Paris-Est; Créteil France

2. INSERM U955; Créteil France

3. Santé Publique France; Saint-Maurice France

4. Clinique d'Hépatogastroentérologie; Centre Hospitalier Universitaire de Grenoble; Grenoble France

5. INSERM U823; Grenoble France

6. Laboratoire de Virologie; Hôpital Robert Debré; Reims France

7. Service d'Hépatogastroentérologie; Hospices Civils de Lyon; Lyon France

8. INSERM U1052, Cancer Research Center of Lyon (CRCL); Lyon France

9. Department of Public Health; Hôpital Henri Mondor; Université Paris-Est; Créteil France

Funder

Santé publique France

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Gliead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.13025/fullpdf

Reference21 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

2. Update on prevention, diagnosis, and treatment and of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance;Terrault;Hepatology,2018

3. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection;Buti;Dig Dis Sci,2015

4. No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B;Kitrinos;Hepatology,2014

5. No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment;Liu;J Viral Hepat,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico;Journal of Clinical and Translational Hepatology;2023-06-07

2. Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing;Hepatology Communications;2023-02-27

3. Traitement de l’hépatite B chronique par ténofovir : aspects virologiques et pharmacologiques;Virologie;2022-05-01

4. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure;Antiviral Research;2021-08

5. Replication of Equine arteritis virus is efficiently suppressed by purine and pyrimidine biosynthesis inhibitors;Scientific Reports;2020-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3